Vancomycin trough plasma concentration monitoring in young infants and children
Postmenstrual age [NB1]: | |
Postmenstrual age: less than 29 weeks | |
Dose interval |
Target range [NB2] |
6 hours [NB3] |
not applicable |
8 hours [NB4] |
not applicable |
12 hours |
14 to 20 mg/L |
24 hours |
10 to 15 mg/L |
Postmenstrual age: 29 to less than 36 weeks | |
Dose interval |
Target range [NB2] |
6 hours |
15 to 20 mg/L |
8 hours |
13 to 20 mg/L |
12 hours |
13 to 20 mg/L |
24 hours |
8 to 15 mg/L |
Postmenstrual age: 36 to 44 weeks | |
Dose interval |
Target range [NB2] |
6 hours |
15 to 20 mg/L |
8 hours |
13 to 20 mg/L |
12 hours |
10 to 15 mg/L |
24 hours |
8 to 15 mg/L |
Postmenstrual age: more than 44 weeks | |
Dose interval |
Target range [NB2] |
6 hours |
15 to 20 mg/L |
8 hours |
10 to 15 mg/L |
12 hours |
8 to 15 mg/L |
24 hours |
8 to 15 mg/L |
Note:
NB1: Postmenstrual age = gestational age (time between the first day of the last menstrual period and birth) + postnatal age (time since birth). NB2: In situations where the risk of not achieving an area under the concentration–time curve over a 24-hour period (AUC24) of 400 to 650 mg.hr/L is unacceptable (eg young infants who are critically ill or unstable), to increase the likelihood of achieving an AUC24 of above 400 mg.hr/L, a trough concentration at the upper end of the trough target range may be preferred. NB3: A dose interval of 6 hours is not recommended for young infants with a postmenstrual age less than 29 weeks because the target trough concentrations required to achieve an AUC24 above 400 mg.hr/L will exceed 20 mg/L. NB4: A dose interval of 8 hours is not recommended for young infants with a postmenstrual age less than 29 weeks because the target trough concentrations required to achieve an AUC24 above 400 mg.hr/L for target attainment will exceed 20 mg/L. |